We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Circassia Group Plc | LSE:CIR | London | Ordinary Share | GB00BJVD3B28 | ORD 0.08P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 34.00 | 33.10 | 34.90 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMCIR
RNS Number : 1477U
Circassia Group Plc
31 March 2021
Circassia Group plc
Block Listing Interim Review
Oxford, UK - 31 March 2021: Circassia Group plc ("Circassia" or "the Company") (LSE: CIR), a medical device company focused on respiratory diagnostics and monitoring, makes the following notification pursuant to Schedule Six of the AIM Rules for Companies regarding its existing block listing arrangements:
Name of the company: Circassia Group plc Name of relevant scheme: 1) Circassia EMI Share Option Scheme 2) Circassia 2007 Unapproved Share Scheme 3) Circassia 2014 Performance Share Plan Scheme 4) Circassia 2015 Performance Share Plan Scheme 5) Circassia 2016 Performance Share Plan Scheme 6) Circassia 2017 Performance Share Plan Scheme ----------------------------------------- Period of return: From: 1 October 2020 To: 31 March 2021 --------- ----------------- ---- ---------------- Balance of unallotted securities 1) 700,750 under scheme(s) from previous 2) 203,000 return: 3) 76,676 4) 251,864 5) 739,905 6) 678,980 Total: 2,651,175 ----------------------------------------- Plus: The amount by which 1) - 6) inclusive: Nil the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): ----------------------------------------- Less: Number of securities 1) - 3) inclusive: Nil issued/allotted under scheme(s) 4) (13,845) during period: 5) (30,362) 6) (281,684) Total: (325,891) ----------------------------------------- Equals: Balance under scheme(s) 1) 700,750 not yet issued/allotted at 2) 203,000 end of period: 3) 76,676 4) 238,019 5) 709,543 6) 397,296 Total: 2,325,284 ----------------------------------------- Number and class of securities 1) 2,600,000 - 20 March 2014 originally listed and the 2) 516,000 - 1 June 2017 date of admission: 3) 500,000 - 1 June 2017 4) 400,000 - 21 May 2018 5) 930,000 - 1 July 2019 6) 980,000 - 22 May 2020 -----------------------------------------
For further information, please contact:
Circassia Tel: +44(0)1865 405566 Sarah Duncan, Company Secretary N+1 Singer (Nominated Adviser and Tel: +44 (0) 20 7496 Broker) 3000 Aubrey Powell / Jen Boorer / Hannah Woodley ------------------------------------- -----------------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
BLRMZGFFMMZGMZM
(END) Dow Jones Newswires
March 31, 2021 07:14 ET (11:14 GMT)
1 Year Circassia Chart |
1 Month Circassia Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions